2024
DOI: 10.1001/jamainternmed.2023.7693
|View full text |Cite
|
Sign up to set email alerts
|

Tecovirimat for Mpox—Promise and Limitations

Jason Zucker,
William A. Fischer,
Timothy Wilkin

Abstract: The findings presented by Aldred et al 1 contribute important preliminary data on the potential efficacy of tecovirimat. However, definitive efficacy data require a randomized clinical trial.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 5 publications
(6 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?